PTEN is a widely well-studied tumor suppressor molecule with significantly decreased PTEN expression in glioblastoma, breast cancer, endometrial cancer, ovarian cancer, lung cancer, prostate cancer, colorectal cancer, and HCC [13–15]. This evidence concerns the gene PTEN and prostate cancer.